Meta-analysis of artificial pancreas trials: methodological considerations - Authors' reply

Affiliations

¹ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Leadership Sinai Centre for Diabetes, Toronto, ON M5T 3L9, Canada; Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: alanna.weisman@mail.utoronto.ca.
² Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Comment

Alanna Weisman et al. Lancet Diabetes Endocrinol. 2017 Sep.

. 2017 Sep;5(9):685-686.

doi: 10.1016/S2213-8587(17)30237-1.

¹ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Leadership Sinai Centre for Diabetes, Toronto, ON M5T 3L9, Canada; Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: alanna.weisman@mail.utoronto.ca.
² Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Toronto, ON, Canada.

No abstract available

Comment on

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Weisman A, et al. Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512. doi: 10.1016/S2213-8587(17)30167-5. Epub 2017 May 19. Lancet Diabetes Endocrinol. 2017. PMID: 28533136
Meta-analysis of artificial pancreas trials: methodological considerations.
Bekiari E, Karagiannis T, Haidich AB, Tsapas A. Bekiari E, et al. Lancet Diabetes Endocrinol. 2017 Sep;5(9):685. doi: 10.1016/S2213-8587(17)30261-9. Lancet Diabetes Endocrinol. 2017. PMID: 28842161 No abstract available.